Medicina
Département
University of Cincinnati
Cincinnati, Estados UnidosPublications en collaboration avec des chercheurs de University of Cincinnati (18)
2023
-
Abnormal physiological findings after FFR-based revascularisation deferral are associated with worse prognosis in women
Scientific Reports, Vol. 13, Núm. 1
-
Changes in microvascular resistance following percutaneous coronary intervention - From the ILIAS global registry
International Journal of Cardiology, Vol. 392
-
Combined use of hyperemic and non-hyperemic pressure ratios for revascularization decision-making: From the ILIAS registry
International Journal of Cardiology, Vol. 370, pp. 105-111
-
Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry
European heart journal, Vol. 44, Núm. 30, pp. 2862-2869
-
Prognostic Implications of Individual and Combinations of Resting and Hyperemic Coronary Pressure and Flow Parameters
JACC: Asia, Vol. 3, Núm. 6, pp. 865-877
-
Sex differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome in symptomatic patients undergoing invasive coronary angiography: Insights from the global ILIAS invasive coronary physiology registry
Atherosclerosis, Vol. 384
2022
-
Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction
Journal of the American Heart Association, Vol. 11, Núm. 9
-
Combined Assessment of FFR and CFR for Decision Making in Coronary Revascularization: From the Multicenter International ILIAS Registry
JACC: Cardiovascular Interventions, Vol. 15, Núm. 10, pp. 1047-1056
-
Differential Impact of Coronary Revascularization on Long-Term Clinical Outcome According to Coronary Flow Characteristics: Analysis of the International ILIAS Registry
Circulation. Cardiovascular interventions, Vol. 15, Núm. 6, pp. e011948
-
Differential Prognostic Value of Revascularization for Coronary Stenosis With Intermediate FFR by Coronary Flow Reserve
JACC: Cardiovascular Interventions, Vol. 15, Núm. 10, pp. 1033-1043
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
-
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 9, pp. 719-728
2021
-
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial
Clinical Infectious Diseases, Vol. 73, Núm. 11, pp. 2009-2022
2020
-
MiR130b from Schlafen4 + MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer
Gut, Vol. 69, Núm. 10, pp. 1750-1761
2018
-
A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii372
2016
2007
-
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials
Journal of the American Medical Association, Vol. 297, Núm. 12, pp. 1332-1343
2005
-
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome study with Tolvaptan (EVEREST)
Journal of Cardiac Failure, Vol. 11, Núm. 4, pp. 260-269